POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 120 | / | 2012 | ||||||||
Date of issue: | 2012-11-29 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Current report 120 buy back 29112012 | |||||||||||
Official market - legal basis | |||||||||||
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
The Board of Directors of SOPHARMA AD (the “Company") hereby informs that from 22 November 2012 up to and including 28 November 2012 the Company bought 6010 own shares representing 0.0045% of the share capital of the Company, to the total value of BGN 13230.96 on the Bulgarian Stock Exchange. The average price per share was BGN 2.20. The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010. The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers. The total number of own shares after these transactions is 3435370, representing 2.60% of the share capital of the Company. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Current report 120 buy back 29112012.doc | Current report 120 buy back 29112012 |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2012-11-29 | Ognian Donev | Executive Director |